24 Paul Tudor Jones II Sangamo Therapeutics Trades
The first Sangamo Therapeutics trade was made in Q2 2013.
Since then Paul Tudor Jones II bought shares twelve more times and sold shares on eleven occasions. The investor completely sold their stake between Q1 2023 and Q4 2024.
Avg closing price
Price range
Sold -363 Thousand shares
Q4 2024
Avg closing price
$1.84
Price range
$0.78
-
$2.87
Sold 3.1% shares (-11.6 Thousand shares)
Q1 2023
Avg closing price
$2.85
Price range
$1.66
-
$3.67
Increased shares by 1100.2% (+344 Thousand shares)
Q4 2022
Avg closing price
$3.88
Price range
$2.77
-
$5.07
Sold 78.3% shares (-113 Thousand shares)
Q3 2022
Avg closing price
$5.14
Price range
$4.27
-
$6.39
Increased shares by 223.7% (+99.7 Thousand shares)
Q2 2022
Avg closing price
$4.32
Price range
$3.28
-
$6.21
Sold 72.5% shares (-117 Thousand shares)
Q1 2022
Avg closing price
$5.95
Price range
$5.23
-
$7.82
Increased shares by 99.1% (+80.6 Thousand shares)
Q4 2021
Avg closing price
$8.69
Price range
$7.29
-
$10.97
New holding (+81.3 Thousand shares)
Q3 2021
Avg closing price
$9.89
Price range
$9.01
-
$12.01
Sold -94.7 Thousand shares
Q4 2020
Avg closing price
$11.71
Price range
$9.23
-
$18.18
Increased shares by 40.1% (+27.1 Thousand shares)
Q3 2020
Avg closing price
$10.82
Price range
$9.38
-
$12.48
New holding (+67.6 Thousand shares)
Q2 2020
Avg closing price
$9.28
Price range
$6.21
-
$11.83
Sold -14.8 Thousand shares
Q1 2019
Avg closing price
$10.21
Price range
$7.72
-
$12.81
New holding (+14.8 Thousand shares)
Q4 2018
Avg closing price
$12.42
Price range
$9.51
-
$16.60
Sold -54.9 Thousand shares
Q1 2018
Avg closing price
$21.38
Price range
$16.70
-
$26.35
Increased shares by 76.9% (+23.9 Thousand shares)
Q4 2017
Avg closing price
$14.88
Price range
$11.60
-
$17.35
Increased shares by 17.0% (+4.5 Thousand shares)
Q3 2017